Wednesday, October 3

6:00 – 7:00pm: Early Career/Trainee Networking Reception with NANETS Leadership

Thursday, October 4

7:30 – 8:30am: Breakfast

8:00 – 10:00am: Allied Health Program 1

  • Review of Treatment Options and Selection: How to Decide
  • Neruoendocrine Nurse Navigation: Comparing Programs
  • Surgical Management of NETs: Long Term Complications and Considerations

8:30 – 10:00am: Early Career Program 1

  • Building an Independent Basic Science Research Program
  • Building an Independent Health Services Research Program

10:00 – 10:30am: Break

10:30 am – 12:30pm: Allied Health Program 2

  • Integrative Oncology
  • Nutritional Issues in the NET Patient
  • Endocrine Management of NETs

10:30 am – 12:30pm: Early Career Program 2

  • Building Multi-Institutional Collaborations
  • Designing and Running a Clinical Trial
  • Work-Life Balance
  • Strategies for Success: Altruism, Failure, and Being a Good Mentee

12:30 – 2:00pm: Lunch Symposium presented by Medscape Education

2:00 – 3:00 pm: Allied Health Program 3

  • PRRT Program Development
  • PRRT Patient Care

2:00 – 3:00pm: Clinical Management 1 - Controversies in Locoregional Management of NETs

  • Ileum NETs
  • Pancreatic NETs
  • Embolotherapies for Liver Metastases: Are They Really Equal

3:00 – 4:00pm: NANETS - SNMMI Symposium

  • NET Imaging: The Role of CT, MRI and PET
  • PRRT Guidelines
  • Future Directions for PRRT

4:00 – 4:20pm: Break

4:20 – 5:20pm: Allied Health Program 4 – NET Research

4:20 – 5:20pm: Tumor Board 1 - Early Disease

  • Optimal Sequence of Therapies for Potentially Resectable Disease

5:30 – 6:30pm: Poster Session Reception

7:00pm: Industry Supported Dinner Symposium

Friday, October 6

7:30 – 8:00pm: Breakfast

8:00 – 9:00am: Clinical Management 2 - Hot Topics in NETs

  • External Beam Radiotherapy in NETS: Have We Reached Full Potential?
  • Immunotherapy in NETs: Is There a Future
  • Introduction of the Well Differentiated G3 NET
  • Debate: G3 Well Differentiated NET: What is the Best Treatment to Start With? Targeted vs. Cytotoxic

9:00 – 10:00am: Research Keynote from John Minna, MD, UT Southwestern

10:00 – 10:30am: Break

10:30 – 11:30am: NET Care Around the World: Sequencing, Integration & Other Challenges

  • NETs in the NHS
  • NETs in the EU
  • NETs in India
  • NETs in Canada

11:30am – 12:30pm: Featured Abstracts 1

12:30 – 2:00pm: Industry Supported Lunch Symposium

2:00 – 3:00pm: Clinical Management 3 - Uncommon NETs

  • A Poster Child for Cancer Metabolism
  • Merkel Cell: Current & Future Therapy
  • 20 Years of MENIN
  • Pituitary Tumors and pNETs: Siblings of Cousins?

3:00 – 4:00pm: NANETS - SIO Symposium

  • Emboman vs. BetaGal: Battle of the Radiologists
  • PRRT Should be 1st-line for Liver-Dominant Metastasis
  • Embolization Remains the Best Option for Liver-Dominant Metastasis
  • Has Y90 Gone Cold for NETs? TARE Causes Long-Term Toxicity and Should be Reserved for 2nd-line
  • TARE Should Remain a 1st-Line Option for Liver Metastasis
  • The Best of Both worlds: Intra-Arterial PRRT

4:00 – 4:20am: Break

4:20 – 5:20pm: Oberndorfer Cup Competition (NET Quiz)

5:20 – 5:45pm: NANETS Awards

6:00 – 7:30pm: Poster Session Reception

Saturday, October 6

7:00 – 8:00am: Breakfast with the Experts

8:05 – 9:00am: Clinical Management 4 - Year in Review

  • New Lung NET Guidelines – NANETS/CommNETS
  • New Trials and Exciting Developments
  • Appropriate Use Criteria for Ga68SR-PET
  • Debate: Should PRRT Be Used in Bronchial NETs

9:00 – 10:00am: Research Didactic Session

  • Spatial Systems Biomedicine
  • Merkell Cell Carcinoma
  • Role of Myc in NE Differentiation, Survival, Resistance in Pancreatic Cancer

10:00 – 10:30am: Break

10:30 – 11:30am: Clinical Management 5 - Patient-Centered Care

  • Measuring Patient-Centered Outcomes and the Patient Experience in NETs
  • Survivorship Issues in NETs
  • Using Population-Based Data to Improve Patient Outcomes in NETs
  • Debate: Is Measuring CGA Routinely in the Best Interest of Our Patients?

11:30 am – 12:30pm: Featured Abstracts 2

12:30 – 2:00pm: Industry Supported Lunch Symposium

2:00 – 2:40pm: NANETS General Session

2:40 – 3:40pm: Tumor Board 2 - Advanced Disease

  • Case 1: Carcinoid With Synchronous Liver Metastasis
  • Gastric Carcinoid
  • Metastatic pNET

3:40 – 4:00pm: Closing Remarks